Skip to content

Clinical trials

Phase 2 Recurrence trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Phase: Phase 2 Country / region: China Clear all

156 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20093
20112
20121
20143
20154
20166
20178
20185
201912
202012
202119
202213
202314
202419
202523
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status48
Recruiting47
Completed33
Not yet recruiting14
Active, not recruiting9
Terminated3
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University12
Peking Union Medical College Hospital6
The First Affiliated Hospital of Soochow University6
Institute of Hematology & Blood Diseases Hospital, China5
Chinese PLA General Hospital4
Ruijin Hospital4
Shanghai Ming Ju Biotechnology Co., Ltd.4
BeiGene3
Beijing InnoCare Pharma Tech Co., Ltd.3
First Affiliated Hospital of Zhejiang University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence156
Lymphoma, Large B-Cell, Diffuse15
Neoplasm Metastasis12
Nasopharyngeal Carcinoma11
Lymphoma, Non-Hodgkin9
Multiple Myeloma9
Leukemia, Myeloid, Acute8
Lymphoma, B-Cell7
Uterine Cervical Neoplasms6
Carcinoma, Hepatocellular5

Trials

Showing 1 to 25 of 156. Each trial links to its page on Pharma Observatory.

56 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.